Anteris Announces $320 Million Capital Raise with Medtronic Strategic Investment

jueves, 22 de enero de 2026, 5:20 pm ET1 min de lectura
AVR--
MDT--

Anteris Technologies Global Corp. has completed a $90 million strategic investment from Medtronic and raised $320 million in gross proceeds to support the global pivotal PARADIGM trial and advance the company's TAVR technology. The investment will aid in the development and commercialization of cutting-edge medical devices to restore healthy heart function.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios